TITLE

Recognizing neuroleptic malignant syndrome

AUTHOR(S)
Rosebush, Patricia I.; Garside, Sarah; Mazurek, Michael F.
PUB. DATE
May 2004
SOURCE
CMAJ: Canadian Medical Association Journal;5/25/2004, Vol. 170 Issue 11, p1645
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor in response to a medical cases reported by Geethan J. Chandran and associates which deals with neuroleptic malignant syndrome.
ACCESSION #
13118760

 

Related Articles

  • Neuroleptic malignant syndrome and catatonia - other diagnostic considerations. Arya, D. K. // Journal of the Royal Society of Medicine;Jan1992, Vol. 85 Issue 1, p60 

    A letter to the editor is presented in response to the article "Neuroleptic malignant syndrome: a diagnostic dilemma," in the August 1991 issue.

  • Neuroleptic malignant syndrome. Larner, Andrew J. // British Journal of Psychiatry;Jun92, Vol. 160, p868 

    A letter to the editor is presented in response to an article about neuroleptic malignant syndrome.

  • Neuroleptic Malignant Syndrome. Tan, T.K.S.; Ong, S.H. // British Journal of Psychiatry;Nov91, Vol. 159, p729 

    A letter to the editor is presented in response to several articles including one about catatonia and another about neuroleptic malignant syndrome.

  • NEUROLEPTIC MALIGNANT SYNDROME. Singh, T. Hari // British Journal of Psychiatry;Jul84, Vol. 145, p98 

    A letter to the editor is presented discussing the signs and symptoms of neuroleptic malignant syndrome.

  • NEUROLEPTIC MALIGNANT SYNDROME. Bhugra, Dinesh // British Journal of Psychiatry;Oct84, Vol. 145, p449 

    A letter to the editor is presented in response to an article about neuroleptic malignant syndrome.

  • Neuroleptic Malignant Syndrome or Lithium Neurotoxicity. Jee, Adityan // British Journal of Psychiatry;Apr87, Vol. 150, p568 

    A letter to the editor is presented commenting on an article on neuroleptic malignant syndrome or lithium neurotoxicity, which was featured in the September 1986 issue.

  • NMS and genetic drug oxidation. Otani, Koichi; Kaneko, Sunao; Fukushima, Yutaka; Chiba, Kan; ishizaki, Takashi // British Journal of Psychiatry;Oct91, Vol. 159, p595 

    A letter to the editor is presented in response to an article about the link between neuroleptic malignant syndrome and genetic drug oxidation.

  • Carbamazepine and NMS. Coulter, Fiona; Corrigan, F. M. // British Journal of Psychiatry;Mar91, Vol. 158, p434 

    A letter to the editor is presented in response to the article about a patient diagnosed with neuroleptic malignant syndrome (NMS) suffering without fever following an overdose of trifluoperazine and carbamazepine in the 1990 issue.

  • Clozapine and NMS. Buckley, Peter F.; Meltzer, Herbert Y. // British Journal of Psychiatry;Apr93, Vol. 162, p566 

    A letter to the editor is presented in response to an article on the relation of Clozapine to the recurrence of neuroleptic malignant syndrome in the December 1992 issue.

  • TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME. White, P. D. // British Journal of Psychiatry;Apr84, Vol. 144, p437 

    A letter to the editor in response to various articles on the treatment of neuroleptic malignant syndrome with dantrolene sodium in the previous issues is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics